Related Experiment Video
Updated: May 10, 2026

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
Published on: May 11, 2018
Linkage-chemistry-regulated activation of ferrocene-functionalized poly(l-lysine) nanoplatforms for synergistic
Fanqiu Zeng1, Jinglong Yang2, Jinghang Li2
1State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, Wuhan 430070, China; Shenzhen Institute of Wuhan University of Technology, Shenzhen 518000, China.
Abstract:
Chemodynamic therapy (CDT) relies on the relatively elevated levels of hydrogen peroxide (H2O2) in the tumor microenvironment (TME) to generate highly reactive hydroxyl radicals (·OH) in situ via Fenton or Fenton-like reactions. However, its therapeutic efficacy is often constrained by the limited intratumoral H2O2 availability and insufficient reaction kinetics at the catalytic centers. To overcome the above-mentioned bottlenecks, this study developed a pH-responsive ferrocene (Fc)-functionalized polymeric nanodelivery system, denoted as ImFc, based on a poly(l-lysine) (PLL) backbone, and incorporated the chemotherapeutic agent doxorubicin (DOX) as an in situ H2O2 amplification factor to achieve combined chemotherapy and CDT. This nanosystem remains structurally stable under physiological conditions but undergoes responsive disassembly in tumor-associated acidic environments, enabling the controlled release of Fc and DOX while activating the cationic properties of PLL to enhance its interactions with negatively charged intracellular biomolecular components. The Fe(II) center of Fc catalyzes the conversion of H2O2 into ·OH, thereby enhancing intracellular oxidative stress and promoting lipid peroxidation-associated damage. In vitro results demonstrated that, compared with the control system AmFc in which Fc was covalently immobilized, ImFc and its drug-loaded formulation exhibited higher levels of ·OH generation and lipid peroxide accumulation, indicating more pronounced ferroptosis-related cellular damage. In a murine orthotopic breast cancer model, ImFc showed a superior trend in tumor growth inhibition compared with AmFc, while both ImFc@DOX and AmFc@DOX further enhanced the antitumor efficacy. Collectively, this study demonstrates that the synergistic integration of pH-responsive release, activation of cationic properties, and substrate-supply amplification effectively improves the therapeutic efficiency and safety of CDT, providing a feasible design strategy for constructing efficient and controllable CDT-based combinational nanoplatforms.
More Related Videos
07:07Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology
Published on: March 12, 2015
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Ligand Binding and Linkage